Nexxen Announces November 2025 Share Repurchase Program Summary

(NasdaqGM:NEXN), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced the Company repurchased 427,500 Ordinary Shares at an average price of $7.11 during November 2025. As of November 30, 2025, Nexxen […]

ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310

ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer's trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310 GlobeNewswire December 01, 2025 Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS' PRECISE-AD trial ProMIS on track to

McFarlane Initiates Environmental Baseline Study Work for Juby

McFarlane Initiates Environmental Baseline Study Work for Juby A Vital Step in Advancing Permitting for Ore Extraction GlobeNewswire December 01, 2025 TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — McFarlane Lake Mining Limited (“McFarlane” or the “Company“) (CSE: MLM, OTC: MLMLF) a leading Canadian gold exploration company focused on advancing its flagship Juby Gold Project, located

Beyond Oil Reports Financial Results for the Third Quarter of 2025

Beyond Oil Reports Financial Results for the Third Quarter of 2025 GlobeNewswire December 01, 2025 Compared to the Previous Corresponding Quarterly Period, Revenue Increased 779% (US$133K to US$1.2M); Increase in Gross Profit; Strong Cash Position Growth Trajectory Remains Strong First Tranche of Previously Shareholder Approved Milestone Shares to be Issued After Reaching US$3M Revenue Milestone

Morien Maiden Drill Program Underway at Lazy Head Aggregate Project

Morien Maiden Drill Program Underway at Lazy Head Aggregate Project GlobeNewswire December 01, 2025 HALIFAX, Nova Scotia, Dec. 01, 2025 (GLOBE NEWSWIRE) — Morien Resources Corp. (“Morien” or the “Company”) (TSX-V: MOX) is pleased to announce that it has commenced a maiden drill program at the Lazy Head Aggregate Project (“Lazy Head” or the “Project”)

Pulse Oil Corp. Announces Amendments to Facility Agreements and Updates EOR Progress

Pulse Oil Corp. Announces Amendments to Facility Agreements and Updates EOR Progress GlobeNewswire December 01, 2025 VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) — Pulse Oil Corp. (“Pulse” or the “Company“) (TSXV: PUL) is pleased to announce that Pulse has entered into amending agreements to the two loan Facility Agreements (the “Facility Agreements“) with

Telix Pharmaceuticals Limited Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TLX

Telix Pharmaceuticals Limited Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TLX GlobeNewswire December 01, 2025 LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ: TLX) for violations

Altimmune Announces CEO Transition and Succession Plan

Altimmune Announces CEO Transition and Succession Plan GlobeNewswire December 01, 2025 Jerry Durso, accomplished industry leader, to succeed Vipin Garg, Ph.D. as Chief Executive Officer Transition follows seven years of strong leadership by Dr. Garg GAITHERSBURG, Md., Dec. 01, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President Carolyn Bonner succeeds James (“Jim”) Quinlan who has resigned for health reasons after taking medical leave in September 2025 GlobeNewswire December 01, 2025 PHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the

Scroll to Top